Skip to content

Reliability of Sensor-Derived Measurements of the SENSorized Fugl-Meyer (FMA) in Subjects with Stroke Outcomes

Reliability of Sensor-Derived Measurements of the SENSorized Fugl-Meyer (FMA) in Subjects with Stroke Outcomes

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06893367
Acronym
FMA-SENS
Enrollment
50
Registered
2025-03-25
Start date
2025-05-31
Completion date
2026-05-31
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

18 Years and Over, Sensorimotor Impairment Affecting the Upper Limb, Stroke

Brief summary

This study will be conducted at a single research center, the main objective of the study will be to evaluate the efficacy, safety, and accuracy of a medical device that has not yet been commercialized; therefore, it is still under development or testing and is not yet available for private use and is not for profit (nonprofit). Fifty participants will be recruited from subjects afferent to the outpatient and inpatient neuro-motor rehabilitation clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and afferent to the outpatient and inpatient rehabilitation clinics of Elias University Emergency Hospital in Bucharest, Romania. In detail, it is deemed necessary to collect clinical and instrumental data. The study will be conducted by an interdisciplinary team composed of healthcare professionals and engineers afferent to the Department of Industrial Engineering. Should you decide to participate in the study, a visit to verify the inclusion and exclusion criteria will be primarily conducted. Once the admission criteria have been verified, participants will undergo a series of assessments. The first, involves the administration of some specific sections of the Fugl-Meyer scale (FMA), focusing on the upper extremities. Specifically, the following will be examined: section A for general upper limb function, section B assessing wrist mobility, and finally section D for limb coordination and speed. During this phase, both upper limbs will be assessed, in addition, the first examiner will carefully place sensors on the participants and assign scores to the tests performed, according to the criteria established by the FMA scale. Next, a second assessment (T1) will be conducted, in which a second examiner will be responsible for placing the sensors and recording data only on the most affected side. At a third time, called T2 and again with at least 15 minutes interval from T1, the first examiner will repeat the same assessments performed in T1. While performing these assessments, a RealSense camera will be used.

Interventions

DEVICEIMU and RealSense Cameras

Each participant will perform the FMA-sens, with their most affected hand, followed by the FMA-sens with the less affected hand.

Sponsors

University of Florence
CollaboratorOTHER
University of Bucharest
CollaboratorOTHER
Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 years or older; * stroke outcomes with the presence of sensorimotor impairment in the upper limb; * willingness to participate in the project, with informed consent signed by the person himself or, when necessary, by the support administrator/legal guardian.

Exclusion criteria

* Severe concomitant pathologies that modify the subject's motor framework; * severe visual and/or hearing impairments that cannot be corrected; * severe neuropsychological impairments (aphasia, apraxia, other cognitive deficits ) such as to prevent cooperation in administering the scale; * presence of signs of clinical instability, defined by a score greater than zero on the SIC scale (Clinical Instability Scale).

Design outcomes

Primary

MeasureTime frameDescription
Participants assessed by IMUbaselineThe Fugl-Meyer Assessment (FMA) is obtained with IMU and RealSense cameras. Below are the individual items of the FMA that will be acquired via the experimental kit: * A II. Voluntary movement in synergy: flexor synergy/extensor synergy * A III. Voluntary movement with mixed synergies: hand to lumbar spine/shoulder flexion 0- 90/pronation-supination * A IV. Voluntary movement with reduced or absent synergy: shoulder abduction 0-90/shoulder flexion 90-180/pronation-supination * B I. Wrist: stability at 15° dorsiflexion with elbow 90° * B II. Wrist: repeated dorsiflexion with elbow 90° * B III. Wrist: Stability at 15° dorsiflexion with elbow at 0° * B IV. Wrist: repeated dorsiflexion with elbow at 0° * D. Coordination/Speed: tremor * D. Coordination/Speed: dysmetria * D. Coordination/Speed: time

Secondary

MeasureTime frameDescription
Total FMA scorebaselineSensorimotor recovery assessment after stroke, total score from 0 to 64, subscore upper limb 36, lower limb 28. Higher scores represent better outcomes.
MODIFIED BARTHEL INDEX (mBI)baselineThe Modified Barthel Index (MBI) is a tool used to assess a person's level of independence in performing activities of daily living, particularly in geriatrics and rehabilitation settings. It consists of 10 activities, such as eating, dressing, using the bathroom, moving around, and personal hygiene, each assigned a specific score. A higher score indicates greater independence, while a lower score reflects a higher level of dependence on assistance. The modified version of the Barthel Index is adapted from the original and is commonly used to track progress during rehabilitation or for patients with disabilities.

Countries

Italy

Contacts

Primary ContactFrancesca Cecchi
fcecchi@dongnocchi.it055/73931

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026